DEVAL L PATRICK
CIK 1053466 · last filed 2026-04-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.50M
Companies
6
Total Filings
64
Lifetime Open-Market Net
-$6.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TOST | Director | 45,815 | $24.82 | $1.14M | -$1.12M | 13 | 2026-04-23 |
| TWLO | Director | 18,327 | $204.08 | $3.74M | $0 | 21 | 2026-03-17 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 13,743 | $44.96 | $617.9K | -$2.22M | 5 | 2024-06-07 |
| AMWL | Director | 177,892 | $9.11 | $1.62M | $150.0K | 6 | 2023-06-26 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$2.83M | 16 | 2022-10-06 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | — | $18.07 | — | $0 | 1 | 2021-02-03 |
Recent Filings · Page 3 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-26 | — | Other (J) | −172,500 | $0 | |
| 2023-06-26 | AMWL | Grant (A) | +91,743 | $0 | EDGAR |
| 2023-06-14 | TWLO | Grant (A) | +1,310 | $0 | EDGAR |
| 2023-06-12 | TOST | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | +3,282 | $0 | EDGAR |
| 2023-06-05 | TOST | Exer (M) | +11,292 | $0 | EDGAR |
| 2023-03-17 | TWLO | Grant (A) | +1,101 | $0 | EDGAR |
| 2023-02-24 | TOST | Exer (M) | +7,640 | $0 | EDGAR |
| 2022-12-19 | TWLO | Grant (A) | +1,565 | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −9,037 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.